Lv0
0 积分 2022-09-22 加入
Capivasertib in Hormone Receptor–Positive Advanced Breast Cancer
1年前
已完结
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer
1年前
已完结
Phase I/II Trial of Exemestane, Ribociclib, and Everolimus in Women with HR+/HER2− Advanced Breast Cancer after Progression on CDK4/6 Inhibitors (TRINITI-1)
2年前
已完结
Overall Survival with Ribociclib plus Endocrine Therapy in Breast Cancer
2年前
已完结
Untangling the ErbB signalling network
2年前
已完结
皖公网安备34019202002308
